Get Premium to unlock powerful stock data
NAS:KRTX (USA)  
Karuna Therapeutics Inc logo

Karuna Therapeutics Inc

$ 124.98 +4.33 (+3.59%) 11:08 PM EST
P/E:
At Loss
P/B:
8.07
Market Cap:
$ 3.73B
Enterprise V:
$ 3.17B
Volume:
304.35K
Avg Vol (2M):
317.53K
Also Trade In:
Volume:
304.35K
Market Cap $:
3.73B
PE Ratio:
At Loss
Avg Vol (2-Month):
317.53K
Enterprise Value $:
3.17B
PB Ratio:
8.07
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Karuna Therapeutics Inc
NAICS : 325412 SIC : 2834
99 High Street, 26th Floor, Boston, MA, USA, 02110
Description
Karuna Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical needs. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues.
Name Current Vs Industry Vs History
Cash-To-Debt 63.51
Equity-to-Asset 0.96
Debt-to-Equity 0.02
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 103.07
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -53
3-Year EPS without NRI Growth Rate -27.9
3-Year FCF Growth Rate -35.7
Name Current Vs Industry Vs History
5-Day RSI 88.92
9-Day RSI 75.79
14-Day RSI 66.76
6-1 Month Momentum % -18.45
12-1 Month Momentum % -3.43

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 29.18
Quick Ratio 29.18
Cash Ratio 27.83
Days Sales Outstanding 17.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.7

Financials (Next Earnings Date:2022-08-05 Est.)

KRTX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:KRTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 36.964
EPS (TTM) ($) -5.78
Beta 2.03
Volatility % 36.34
14-Day RSI 66.76
14-Day ATR ($) 6.026082
20-Day SMA ($) 108.1835
12-1 Month Momentum % -3.43
52-Week Range ($) 92.26 - 161.98
Shares Outstanding (Mil) 29.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Karuna Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More